Lexeo Therapeutics Inc.
LXEO
Valuation & Multiples
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue
N/A
Net Income (TTM)
-$105M
▼ -1.7% YoY
Op. Margin
–
ROIC
-37.55%
▲ +21.1pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$87M
▼ -21.2% YoY
Op. Cash Flow (TTM)
-$87M
▼ -21.5% YoY
Net Debt
-$189M
Net Cash Position
Cash & Equiv.
$195M
Continue Research
Peers
Biological Products, (No Diagnostic Substances) · Pick stocks to compare with LXEO
Held by ETFs
LXEO is in 14 US ETFs. The largest of them, with LXEO's weight in each:
iShares Russell 2000 Value ETFIWN0.01%of the fund
State Street SPDR S&P Biotech ETFXBI0.05%of the fund
iShares Biotechnology ETFIBB0.01%of the fund
Fidelity Enhanced Small Cap ETFFESM0.01%of the fund
State Street SPDR S&P Kensho New Economies Composite ETFKOMP0.07%of the fund
iShares Micro-Cap ETFIWC0.05%of the fund
Lexeo Therapeutics (LXEO) in three numbers
Questions about Lexeo Therapeutics
Is Lexeo Therapeutics a high-quality business?
Lexeo Therapeutics scores 10 out of 100 on Intrinsiqq's quality score, which makes it a lower-quality business on these measures. The score blends 3 checks computed from SEC filings. Its best check is net debt at -$189M, and its weakest is return on capital at -37.6%. The Quality tab shows every check against its target.
Does Lexeo Therapeutics (LXEO) pay a dividend?
No. Lexeo Therapeutics (LXEO) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.
Source: 10-Q filed 12 Nov 2026 (period ending 30 Sept 2026), SEC. Price: last close 20 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.
Spot a number that looks wrong? Check it in LXEO's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing LXEO
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.